| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458406A1 A method of treatment and agents useful for same |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 09/22/2004 | EP1458349A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458347A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458242A2 Polyvalent conjugate vaccine for cancer |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531528A Dibenzocycloheptene compound |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1531438A Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530101A Healthy food composition for purifying blood, improving immunity and regulating blood fat |
| 09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167462C Medicinal composition containing cyclosporin |
| 09/22/2004 | CN1167457C Instant powder containing Radix Astragalus seu hedysari, Herba Dendrobii, Frutus crataegi, and its preparation |
| 09/22/2004 | CN1167427C Preparing method of life prolonging preparation |
| 09/22/2004 | CN1167423C Means for treating radiation injuries |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794360 Using histacalin protein in the manufacture of a medicament for the treatment or prevention of allergic rhinitis |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6794128 Methods of selecting internalizing antibodies |
| 09/21/2004 | US6793933 Dietary supplements for enhancing the immune system |
| 09/21/2004 | US6793928 Vaccines with an LTB adjuvant |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/16/2004 | WO2004078957A1 DENDRITIC CELL PRESENTING α-GLYCOSYLCERAMIDE DERIVATIVE AND ANTIGEN AND USABLE IN SUPPRESSING IMMUNE RESPONSE |
| 09/16/2004 | WO2004078940A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 09/16/2004 | WO2004078756A2 Jnk inhibitors |
| 09/16/2004 | WO2004078751A1 Benzofuran derivative |
| 09/16/2004 | WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 09/16/2004 | WO2004078188A1 COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION |
| 09/16/2004 | WO2004078175A2 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases |
| 09/16/2004 | WO2004055513A3 Use of cd137 antagonists for the treatment of tumors |
| 09/16/2004 | WO2004050096A3 Phosphoantigens for regulating an immune response |
| 09/16/2004 | WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 09/16/2004 | WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen |
| 09/16/2004 | WO2003092586A3 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 09/16/2004 | WO2003073989A3 Nucleoside 5'-monophosphate mimics and their prodrugs |
| 09/16/2004 | WO2003066063A8 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2003026690A9 Incapacitated whole-cell immunogenic bacterial compositions |
| 09/16/2004 | WO2002050097A3 Anti-allergic complex molecules |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181039 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | US20040180962 Dosage forms having prolonged active ingredient release |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 09/16/2004 | US20040180938 More preferred compound is (1Z,3E)-1-methyl-1-(4-carboxyphenyl)-2-methoxycarbonyl-3-(2-methylpyridin-4-yl)aminocarbonyl-4-(3-methoxyphenyl)butadiene; for the treatment of acute coronary symptoms |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180934 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 09/16/2004 | US20040180926 Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 09/16/2004 | US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate |